Psoriasis: Behind the scenes
Psoriasis is a chronic inflammatory skin disease characterized by a significant deterioration in the quality of life of affected individuals. Notably, psoriasis is significantly associated with cardiovascular and metabolic syndrome and other autoimmune disorders. Recent progress in biologic therapie...
Gespeichert in:
| Veröffentlicht in: | Journal of dermatology 2016-01, Vol.43 (1), p.4-8 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 8 |
|---|---|
| container_issue | 1 |
| container_start_page | 4 |
| container_title | Journal of dermatology |
| container_volume | 43 |
| creator | Furue, Masutaka Kadono, Takafumi |
| description | Psoriasis is a chronic inflammatory skin disease characterized by a significant deterioration in the quality of life of affected individuals. Notably, psoriasis is significantly associated with cardiovascular and metabolic syndrome and other autoimmune disorders. Recent progress in biologic therapies has revealed the fundamental role of tumor necrosis factor‐α, interleukin (IL)‐23 and the IL‐17A axis together with aberrant overproduction of epidermal IL‐36γ in the pathogenesis of psoriasis. This review provides an update on the clinical, pathological and therapeutic advancements involving psoriasis. |
| doi_str_mv | 10.1111/1346-8138.13186 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785230924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1785230924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5736-ff93cd1c7e9e457655b4f9e5520e84279e0656c26afe6d5f1a11cba38501dbad3</originalsourceid><addsrcrecordid>eNqNkM1PwjAchhujEUTPXowh8eJl0I_1Y94UAUWCHvxIvDTd9lsYjg1XFuW_tzjh4EV7adI875u3D0LHBHeIO13CfOEpwlSHMKLEDmpuX3ZREzPFPepj2UAH1s4wpgEneB81qJCKYoyb6OTBFmVqbGov2lcwTfO4vZxC20aQgz1Ee4nJLBz93C30NOg_9m688f3wtnc59iIumfCSJGBRTCIJAfhcCs5DPwmAc4pB-VQGgAUXERUmARHzhBhCotC4cZjEoYlZC53XvYuyeK_ALvU8dQuyzORQVFYTqThlOKD-P1CBA0Yo5Q49-4XOiqrM3UccxWXgKzfOUd2aisrC2hISvSjTuSlXmmC9dqzXRvXaqP527BKnP71VOId4y2-kOoDXwEeaweqvPj267m-KvTqX2iV8bnOmfNNCMsn1y2SoR8-Du4nPXzVlX2M3kRE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1757948842</pqid></control><display><type>article</type><title>Psoriasis: Behind the scenes</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Furue, Masutaka ; Kadono, Takafumi</creator><creatorcontrib>Furue, Masutaka ; Kadono, Takafumi</creatorcontrib><description>Psoriasis is a chronic inflammatory skin disease characterized by a significant deterioration in the quality of life of affected individuals. Notably, psoriasis is significantly associated with cardiovascular and metabolic syndrome and other autoimmune disorders. Recent progress in biologic therapies has revealed the fundamental role of tumor necrosis factor‐α, interleukin (IL)‐23 and the IL‐17A axis together with aberrant overproduction of epidermal IL‐36γ in the pathogenesis of psoriasis. This review provides an update on the clinical, pathological and therapeutic advancements involving psoriasis.</description><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.13186</identifier><identifier>PMID: 26782000</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Autoimmunity ; Biological Products - therapeutic use ; Biological Therapy ; Humans ; interleukin-17 ; interleukin-23 ; interleukin-36γ ; Psoriasis ; Psoriasis - etiology ; Psoriasis - immunology ; Psoriasis - therapy ; tumor necrosis factor-α</subject><ispartof>Journal of dermatology, 2016-01, Vol.43 (1), p.4-8</ispartof><rights>2016 Japanese Dermatological Association</rights><rights>2016 Japanese Dermatological Association.</rights><rights>Copyright © 2016 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5736-ff93cd1c7e9e457655b4f9e5520e84279e0656c26afe6d5f1a11cba38501dbad3</citedby><cites>FETCH-LOGICAL-c5736-ff93cd1c7e9e457655b4f9e5520e84279e0656c26afe6d5f1a11cba38501dbad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.13186$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.13186$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26782000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Furue, Masutaka</creatorcontrib><creatorcontrib>Kadono, Takafumi</creatorcontrib><title>Psoriasis: Behind the scenes</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>Psoriasis is a chronic inflammatory skin disease characterized by a significant deterioration in the quality of life of affected individuals. Notably, psoriasis is significantly associated with cardiovascular and metabolic syndrome and other autoimmune disorders. Recent progress in biologic therapies has revealed the fundamental role of tumor necrosis factor‐α, interleukin (IL)‐23 and the IL‐17A axis together with aberrant overproduction of epidermal IL‐36γ in the pathogenesis of psoriasis. This review provides an update on the clinical, pathological and therapeutic advancements involving psoriasis.</description><subject>Autoimmunity</subject><subject>Biological Products - therapeutic use</subject><subject>Biological Therapy</subject><subject>Humans</subject><subject>interleukin-17</subject><subject>interleukin-23</subject><subject>interleukin-36γ</subject><subject>Psoriasis</subject><subject>Psoriasis - etiology</subject><subject>Psoriasis - immunology</subject><subject>Psoriasis - therapy</subject><subject>tumor necrosis factor-α</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkM1PwjAchhujEUTPXowh8eJl0I_1Y94UAUWCHvxIvDTd9lsYjg1XFuW_tzjh4EV7adI875u3D0LHBHeIO13CfOEpwlSHMKLEDmpuX3ZREzPFPepj2UAH1s4wpgEneB81qJCKYoyb6OTBFmVqbGov2lcwTfO4vZxC20aQgz1Ee4nJLBz93C30NOg_9m688f3wtnc59iIumfCSJGBRTCIJAfhcCs5DPwmAc4pB-VQGgAUXERUmARHzhBhCotC4cZjEoYlZC53XvYuyeK_ALvU8dQuyzORQVFYTqThlOKD-P1CBA0Yo5Q49-4XOiqrM3UccxWXgKzfOUd2aisrC2hISvSjTuSlXmmC9dqzXRvXaqP527BKnP71VOId4y2-kOoDXwEeaweqvPj267m-KvTqX2iV8bnOmfNNCMsn1y2SoR8-Du4nPXzVlX2M3kRE</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Furue, Masutaka</creator><creator>Kadono, Takafumi</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201601</creationdate><title>Psoriasis: Behind the scenes</title><author>Furue, Masutaka ; Kadono, Takafumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5736-ff93cd1c7e9e457655b4f9e5520e84279e0656c26afe6d5f1a11cba38501dbad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Autoimmunity</topic><topic>Biological Products - therapeutic use</topic><topic>Biological Therapy</topic><topic>Humans</topic><topic>interleukin-17</topic><topic>interleukin-23</topic><topic>interleukin-36γ</topic><topic>Psoriasis</topic><topic>Psoriasis - etiology</topic><topic>Psoriasis - immunology</topic><topic>Psoriasis - therapy</topic><topic>tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Furue, Masutaka</creatorcontrib><creatorcontrib>Kadono, Takafumi</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Furue, Masutaka</au><au>Kadono, Takafumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psoriasis: Behind the scenes</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2016-01</date><risdate>2016</risdate><volume>43</volume><issue>1</issue><spage>4</spage><epage>8</epage><pages>4-8</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><abstract>Psoriasis is a chronic inflammatory skin disease characterized by a significant deterioration in the quality of life of affected individuals. Notably, psoriasis is significantly associated with cardiovascular and metabolic syndrome and other autoimmune disorders. Recent progress in biologic therapies has revealed the fundamental role of tumor necrosis factor‐α, interleukin (IL)‐23 and the IL‐17A axis together with aberrant overproduction of epidermal IL‐36γ in the pathogenesis of psoriasis. This review provides an update on the clinical, pathological and therapeutic advancements involving psoriasis.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>26782000</pmid><doi>10.1111/1346-8138.13186</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0385-2407 |
| ispartof | Journal of dermatology, 2016-01, Vol.43 (1), p.4-8 |
| issn | 0385-2407 1346-8138 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1785230924 |
| source | MEDLINE; Wiley Online Library Journals |
| subjects | Autoimmunity Biological Products - therapeutic use Biological Therapy Humans interleukin-17 interleukin-23 interleukin-36γ Psoriasis Psoriasis - etiology Psoriasis - immunology Psoriasis - therapy tumor necrosis factor-α |
| title | Psoriasis: Behind the scenes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T15%3A25%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psoriasis:%20Behind%20the%20scenes&rft.jtitle=Journal%20of%20dermatology&rft.au=Furue,%20Masutaka&rft.date=2016-01&rft.volume=43&rft.issue=1&rft.spage=4&rft.epage=8&rft.pages=4-8&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.13186&rft_dat=%3Cproquest_cross%3E1785230924%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1757948842&rft_id=info:pmid/26782000&rfr_iscdi=true |